FKTN and muscular dystrophy: Here, we provide evidence of increased mTORC1 activation in aged Fktn-deficient muscle, a model of moderate to severe muscular dystrophy; however, changes in mTOR signaling were not intrinsic to the dystroglycan glycosylation defect as they did not arise until after the development of muscle pathology.